VPC-70619 is a potent N-Myc inhibitor. VPC-70619 blocks the binding of the N-Myc-Max heterocomplex to the DNA E-box and exhibits potent inhibitory activity against N-Myc-dependent cell lines. VPC-70619 can partially reverse paclitaxel (HY-B0015) resistance in cells by reducing MYCN expression. VPC-70619 can be used for cancer research (e.g., neuroblastoma and thyroid cancer)[1][2].
Molecular Weight:
364.71
Purity:
99.93
CAS Number:
[2361742-30-3]
Formula:
C16H8ClF3N4O
Target:
c-Myc
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted